Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2011809
Max Phase: Preclinical
Molecular Formula: C13H14N4O
Molecular Weight: 242.28
Molecule Type: Small molecule
Associated Items:
ID: ALA2011809
Max Phase: Preclinical
Molecular Formula: C13H14N4O
Molecular Weight: 242.28
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 1,3-Bis(3-Aminophenyl)Urea
Synonyms from Alternative Forms(1):
Canonical SMILES: Nc1cccc(NC(=O)Nc2cccc(N)c2)c1
Standard InChI: InChI=1S/C13H14N4O/c14-9-3-1-5-11(7-9)16-13(18)17-12-6-2-4-10(15)8-12/h1-8H,14-15H2,(H2,16,17,18)
Standard InChI Key: IKLYNYSRJGANON-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 242.28 | Molecular Weight (Monoisotopic): 242.1168 | AlogP: 2.50 | #Rotatable Bonds: 2 |
Polar Surface Area: 93.17 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.47 | CX Basic pKa: 4.16 | CX LogP: 1.46 | CX LogD: 1.46 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.61 | Np Likeness Score: -1.03 |
1. Radi M, Falchi F, Garbelli A, Samuele A, Bernardo V, Paolucci S, Baldanti F, Schenone S, Manetti F, Maga G, Botta M.. (2012) Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors., 22 (5): [PMID:22300661] [10.1016/j.bmcl.2011.12.135] |
2. Brai A, Trivisani CI, Poggialini F, Pasqualini C, Vagaggini C, Dreassi E.. (2022) DEAD-Box Helicase DDX3X as a Host Target against Emerging Viruses: New Insights for Medicinal Chemical Approaches., 65 (15.0): [PMID:35899912] [10.1021/acs.jmedchem.2c00755] |
Source(1):